Wenxin (Vincent) Xu, MD presents a potential biomarker (KIM-1) - Quiz - MDSpire

Wenxin (Vincent) Xu, MD presents a potential biomarker (KIM-1)

Evaluation of circulating kidney injury marker-1 (KIM-1) as a prognostic and predictive biomarker in advanced renal cell carcinoma (aRCC): Post-hoc analysis of CheckMate 214.

  • February 26, 2025

Share

Original Source(s)

Wenxin (Vincent) Xu, MD presents a potential biomarker (KIM-1)

  • February 26, 2025

Related Content

Deciphering the Mechanistic Landscape of Immune Checkpoint Blockade in ccRCC: From Molecular Drivers to Therapeutic Responses

Computed tomography guided microwave ablation for the treatment of clinical T1a renal cell carcinoma: a comparison to robot-assisted laparoscopic partial nephrectomy

International metastatic renal cell carcinoma database consortium classification and regression tree analysis to characterize objective response rates to first line in metastatic renal cell carcinoma